share_log

Guggenheim Maintains Buy on The Oncology Institute, Lowers Price Target to $6

Benzinga Real-time News ·  Nov 11, 2022 08:46

Guggenheim analyst Sandy Draper maintains The Oncology Institute (NASDAQ:TOI) with a Buy and lowers the price target from $7 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment